Biallelic variants in HECT E3 paralogs, HECTD4 and UBE3C, encoding ubiquitin ligases cause neurodevelopmental disorders that overlap with Angelman syndrome

Published:November 19, 2022DOI:



      Pathogenic variants in genes encoding ubiquitin E3 ligases are known to cause neurodevelopmental syndromes. Additional neurodevelopmental disorders associated with the other genes encoding E3 ligases are yet to be identified.


      Chromosomal analysis and exome sequencing were used to identify the genetic causes in 10 patients from 7 unrelated families with syndromic neurodevelopmental, seizure, and movement disorders and neurobehavioral phenotypes.


      In total, 4 patients were found to have 3 different homozygous loss-of-function (LoF) variants, and 3 patients had 4 compound heterozygous missense variants in the candidate E3 ligase gene, HECTD4, that were rare, absent from controls as homozygous, and predicted to be deleterious in silico. In 3 patients from 2 families with Angelman-like syndrome, paralog-directed candidate gene approach detected 2 LoF variants in the other candidate E3 ligase gene, UBE3C, a paralog of the Angelman syndrome E3 ligase gene, UBE3A. The RNA studies in 4 patients with LoF variants in HECTD4 and UBE3C provided evidence for the LoF effect.


      HECTD4 and UBE3C are novel biallelic rare disease genes, expand the association of the other HECT E3 ligase group with neurodevelopmental syndromes, and could explain some of the missing heritability in patients with a suggestive clinical diagnosis of Angelman syndrome.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      ACMG Member Login

      Are you an ACMG Member? Sign in for online access.


      Subscribe to Genetics in Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hicke L.
        • Dunn R.
        Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins.
        Annu Rev Cell Dev Biol. 2003; 19: 141-172
        • Goto J.
        • Otaki Y.
        • Watanabe T.
        • Watanabe M.
        The role of HECT-type E3 ligase in the development of cardiac disease.
        Int J Mol Sci. 2021; 22: 6065
        • Rape M.
        Ubiquitylation at the crossroads of development and disease.
        Nat Rev Mol Cell Biol. 2018; 19: 59-70
        • Wang Y.
        • Argiles-Castillo D.
        • Kane E.I.
        • Zhou A.
        • Spratt D.E.
        HECT E3 ubiquitin ligases – emerging insights into their biological roles and disease relevance.
        J Cell Sci. 2020; 133 (J Cell Sci. 2020;133(7):jcs228072. Published correction appears in): jcs258087
        • Rotin D.
        • Kumar S.
        Physiological functions of the HECT family of ubiquitin ligases.
        Nat Rev Mol Cell Biol. 2009; 10: 398-409
        • Moortgat S.
        • Berland S.
        • Aukrust I.
        • et al.
        HUWE1 variants cause dominant X-linked intellectual disability: a clinical study of 21 patients.
        Eur J Hum Genet. 2018; 26: 64-74
        • Zhang J.
        • Gambin T.
        • Yuan B.
        • et al.
        Haploinsufficiency of the E3 ubiquitin-protein ligase gene TRIP12 causes intellectual disability with or without autism spectrum disorders, speech delay, and dysmorphic features.
        Hum Genet. 2017; 136 (Published correction appears in Hum Genet. 2017;136(8):1009-1011.): 377-386
        • Akawi N.
        • McRae J.
        • Ansari M.
        • et al.
        Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families.
        Nat Genet. 2015; 47: 1363-1369
        • Monaghan K.G.
        • Wiktor A.
        • Van Dyke D.L.
        Diagnostic testing for Prader-Willi syndrome and Angelman syndrome: a cost comparison.
        Genet Med. 2002; 4: 448-450
        • Basel-Vanagaite L.
        • Dallapiccola B.
        • Ramirez-Solis R.
        • et al.
        Deficiency for the ubiquitin ligase UBE3B in a blepharophimosis-ptosis- intellectual-disability syndrome.
        Am J Hum Genet. 2012; 91: 998-1010
        • Sobreira N.
        • Schiettecatte F.
        • Valle D.
        • Hamosh A.
        GeneMatcher: a matching tool for connecting investigators with an interest in the same gene.
        Hum Mutat. 2015; 36: 928-930
        • Mitani T.
        • Isikay S.
        • Gezdirici A.
        • et al.
        High prevalence of multilocus pathogenic variation in neurodevelopmental disorders in the Turkish population.
        Am J Hum Genet. 2021; 108: 1981-2005
        • Huibregtse J.M.
        • Scheffner M.
        • Beaudenon S.
        • Howley P.M.
        A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase.
        Proc Natl Acad Sci U S A. 1995; 92 (Proc Natl Acad Sci U S A. 1995;92(7):2563-2567. Published correction appears in): 5249
        • Kumar S.
        • Kao W.H.
        • Howley P.M.
        Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity.
        J Biol Chem. 1997; 272: 13548-13554
        • Hatakeyama S.
        • Jensen J.P.
        • Weissman A.M.
        Subcellular localization and ubiquitin-conjugating enzyme (E2) interactions of mammalian HECT family ubiquitin protein ligases.
        J Biol Chem. 1997; 272: 15085-15092
        • Kosmicki J.A.
        • Samocha K.E.
        • Howrigan D.P.
        • et al.
        Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.
        Nat Genet. 2017; 49: 504-510
        • Husson T.
        • Lecoquierre F.
        • Cassinari K.
        • et al.
        Rare genetic susceptibility variants assessment in autism spectrum disorder: detection rate and practical use.
        Transl Psychiatry. 2020; 10: 77
        • De Rubeis S.
        • He X.
        • Goldberg A.P.
        • et al.
        Synaptic, transcriptional and chromatin genes disrupted in autism.
        Nature. 2014; 515: 209-215
        • C Yuen R.K.
        • Merico D.
        • Bookman M.
        • et al.
        Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder.
        Nat Neurosci. 2017; 20: 602-611
        • Chen Y.H.
        • Huang T.Y.
        • Lin Y.T.
        • et al.
        VPS34 K29/K48 branched ubiquitination governed by UBE3C and TRABID regulates autophagy, proteostasis and liver metabolism.
        Nat Commun. 2021; 12: 1322
        • Sato M.
        Early origin and evolution of the Angelman syndrome ubiquitin ligase gene Ube3a.
        Front Cell Neurosci. 2017; 11: 62
        • Buiting K.
        • Williams C.
        • Horsthemke B.
        Angelman syndrome-insights into a rare neurogenetic disorder.
        Nat Rev Neurol. 2016; 12: 584-593
        • Sell G.L.
        • Margolis S.S.
        From UBE3A to Angelman syndrome: a substrate perspective.
        Front Neurosci. 2015; 9: 322
        • O’Roak B.J.
        • Vives L.
        • Girirajan S.
        • et al.
        Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.
        Nature. 2012; 485: 246-250
        • Ambrozkiewicz M.C.
        • Cuthill K.J.
        • Harnett D.
        • Kawabe H.
        • Tarabykin V.
        Molecular evolution, neurodevelopmental roles and clinical significance of HECT-type UBE3 E3 ubiquitin ligases.
        Cells. 2020; 9: 2455
        • Simchi L.
        • Kaphzan H.
        Aberrant aggressive behavior in a mouse model of Angelman syndrome.
        Sci Rep. 2021; 11: 47
        • Giroud M.
        • Daubail B.
        • Khayat N.
        • et al.
        Angelman syndrome: a case series assessing neurological issues in adulthood.
        Eur Neurol. 2015; 73: 119-125
        • Williams C.A.
        • Driscoll D.J.
        • Dagli A.I.
        Clinical and genetic aspects of Angelman syndrome.
        Genet Med. 2010; 12: 385-395